FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOUCHÉ, M.
Right arrow Articles by MOLINARO, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOUCHÉ, M.
Right arrow Articles by MOLINARO, M.
(The FASEB Journal. 2000;14:1147-1158.)
© 2000 FASEB

TGF-ß autocrine loop regulates cell growth and myogenic differentiation in human rhabdomyosarcoma cells

MARINA BOUCHÉ1, RITA CANIPARI, ROBERTA MELCHIONNA, DANIELA WILLEMS, MARIA I. SENNI and MARIO MOLINARO

Department of Histology and Medical Embryology, University of Rome ‘La Sapienza’, 00161, Rome, Italy

1Correspondence: Department of Histology and Medical Embryology, University of Rome ‘La Sapienza’, Via A. Scarpa 14, 00161, Rome, Italy. E-mail: bouche{at}uniroma1.it

Transforming growth factor ß (TGF) is a well-known inhibitor of myogenic differentiation as well as an autocrine product of rhabdomyosarcoma cells. We studied the role of the TGF-ß autocrine loop in regulating growth and myogenic differentiation in the human rhabdomyosarcoma cell line, RD. We previously reported that the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) induces growth arrest and myogenic differentiation in these cells, which constitutively express muscle regulatory factors. We show that TPA inhibits the activation of secreted latent TGF-ß, thus decreasing the concentration of active TGF-ß to which the cells are exposed. This event is mediated by the TPA-induced alteration of the uPA/PAI serine-protease system. Complete removal of TGF-ß, mediated by the ectopic expression of a soluble type II TGF-ß receptor dominant negative cDNA, induces growth arrest, but does not trigger differentiation. In contrast, a reduction in the TGF-ß concentration, to a range of 0.14–0.20 x 10-2 ng/ml (which is similar to that measured in TPA-treated cells), mimics TPA-induced differentiation. Taken together, these data demonstrate that cell growth and suppression of differentiation in rhabdomyosarcoma cells require overproduction of active TGF-ß; furthermore, they show that a ‘critical’ concentration of TGF-ß is necessary for myogenic differentiation to occur, whereas myogenesis is abolished below and above this concentration. By impairing the TGF-ß autocrine loop, TPA stabilizes the factor concentration within the range compatible for differentiation to occur. In contrast, in human primary muscle cells a much higher concentration of exogenous TGF-ß is required for the differentiation inhibitory effect and TPA inhibits differentiation in these cells probably through a TGF-ß independent mechanism. These data thus clarify the mechanism underlying the multiple roles of TGF-ß in the regulation of both the transformed and differentiated phenotype.—Bouché, M., Canipari, R., Melchionna, R., Willems, D., Senni, M. I., Molinaro, M. TGF-ß autocrine loop regulates cell growth and myogenic differentiation in human rhabdomyosarcoma cells.


Key Words: TPA • serine-protease system • muscle regulatory factors • RD cells




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Croci, L. Landuzzi, A. Astolfi, G. Nicoletti, A. Rosolen, F. Sartori, M. Y. Follo, N. Oliver, C. De Giovanni, P. Nanni, et al.
Inhibition of Connective Tissue Growth Factor (CTGF/CCN2) Expression Decreases the Survival and Myogenic Differentiation of Human Rhabdomyosarcoma Cells
Cancer Res., March 1, 2004; 64(5): 1730 - 1736.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Wang, S. R. Thomson, J. D. Starkey, J. L. Page, A. D. Ealy, and S. E. Johnson
Transforming Growth Factor {beta}1 Is Up-regulated by Activated Raf in Skeletal Myoblasts but Does Not Contribute to the Differentiation-defective Phenotype
J. Biol. Chem., January 23, 2004; 279(4): 2528 - 2534.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
S. V. L. Loducca, A. Mantesso, E. M. F. De Oliveira, and V. C. De Araujo
Intraosseous Rhabdomyosarcoma of the Mandible: A Case Report
International Journal of Surgical Pathology, January 1, 2003; 11(1): 57 - 60.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
A. Mauro, C. Ciccarelli, P. De Cesaris, A. Scoglio, M. Bouche, M. Molinaro, A. Aquino, and B. M. Zani
PKC{alpha}-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells
J. Cell Sci., September 15, 2002; 115(18): 3587 - 3599.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by The Federation of American Societies for Experimental Biology.